Projects in Drug development

The project aimed to replace chlorinated solvents, which are unsuitable from both sustainability and health aspects, in a critical step of the manufacturing process of the active pharmaceutical ingredient vipoglanstat.

How can policy and regulation keep pace with the rapid advancement of medical technology? The project Future Policy for the Future of Precision Medicine explores how governance can enable innovative, safe and personalized healthcare.

Nanoparticle platforms for the delivery of RNA adjuvant and mRNA vaccines offer huge potential for innovation in vaccine technology and drug delivery. One of the benefits is the ability of nanoparticles to protect fragile RNA molecules from degradation by nucleases in the body, increasing the stabi…

The project goal was to establish a solvent-free manufacturing process of lipid mixtures from Emulsi Biotech. These lipid-based systems, based on natural vegetable oils, are intended for oral pharmaceuticals.

PHARMECO aims to drive a green transition in the manufacture of medicine and reduce the environmental impact of (bio)pharmaceutical manufacturing routes.

In Sweden over 85 000 people live with inflammatory bowel disease, IBD. These chronic diseases are complex and can entail big individual variations. A major step is now being undertaken to improve the treatment of people with IBD through collaboration on precision medicine tools and methods.

This project aims to explore the physical state of APIs within mesoporous magnesium carbonate (MMC) pores using X-ray beams. The investigations aim to uncover mechanisms driving drug precipitation, providing essential insights into release behavior. These findings have the potential to refine drug …

RISE, KI, NorthXBiologics and Vecura formed this consortium with the aim to building a national infrastructure around gene therapies through exploring the possibilities of dry vaccines.

RISE participate in international research project to develop and evaluate new inhalation formulations for antibiotic to treat lower respiratory tract infections. 

PLATINEA is a multisectoral collaboration platform with the aim to preserve and enhance the value of existing antibiotics. PLATINEA consists of 23 partners from academia, authorities, industry and healthcare. The common goal is to ensure that antibiotics available today are used in the best way and…

Many infection-causing bacteria have developed a strong resistance against commercial available antibiotics and there is a great need for novel innovative treatments. In a sub-project of FORMAMP, antimicrobial peptides were loaded into lipid nanoparticles for protection and delivery of these sensit…